Synthesis and preliminary evaluation of trans-3,4-conformationally-restricted glutamate and pyroglutamate analogues as novel EAAT2 inhibitors

被引:9
|
作者
Denton, TT
Seib, T
Bridges, RJ
Thompson, CM [1 ]
机构
[1] Univ Montana, Dept Chem, Missoula, MT 59812 USA
[2] Univ Montana, COBRE Ctr Struct & Funct Neurosci, Dept Pharmaceut Sci, Missoula, MT 59812 USA
关键词
D O I
10.1016/S0960-894X(02)00520-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Select trans-4,5-[bi]cyclohexenylglutamic and pyroglutamic acids (3,4-substituted glutamates) were synthesized in three steps and were screened as potential inhibitors of the sodium dependent excitatory amino acid transporters 2 (EAAT2) and 3 (EAAT3), the chloride dependent glial cystine/glutamate exchanger system x(c)(-), and the glutamate vesicular transport system (VGLUT). Two glutamate analogues and one pyroglutamate analogue were found to inhibit EAAT2 with activity comparable to dihydrokainate. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3209 / 3213
页数:5
相关论文
共 50 条
  • [42] Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Mai, A
    Sbardella, G
    Artico, M
    Ragno, R
    Massa, S
    Novellino, E
    Greco, G
    Lavecchia, A
    Musiu, C
    La Colla, M
    Murgioni, C
    La Colla, P
    Loddo, R
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (16) : 2544 - 2554
  • [43] Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N-arylpiperazine Derivatives Characterized as D2/D3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases
    da Silva Cunha, Thayssa Tavares
    Silva, Rafaela Ribeiro
    Rodrigues, Daniel Alencar
    Murteira Pinheiro, Pedro de Sena
    Kronenberger, Thales
    Sant'Anna, Carlos Mauricio R.
    Noel, Francois
    Manssour Fraga, Carlos Alberto
    BIOMOLECULES, 2022, 12 (08)
  • [44] Synthesis and Biological Evaluation of Thieno[3,2-d]-pyrimidinones, Thieno[3,2-d]pyrimidines and Quinazolinones: Conformationally Restricted 17β-Hydroxysteroid Dehydrogenase Type 2 (17β-HSD2) Inhibitors
    Perspicace, Enrico
    Marchais-Oberwinkler, Sandrine
    Hartmann, Rolf W.
    MOLECULES, 2013, 18 (04) : 4487 - 4509
  • [45] Development of pyrazolo[3,4-d]pyrimidin-4-one scaffold as novel CDK2 inhibitors: Design, synthesis, and biological evaluation
    Xie, Fan
    Zhou, Liying
    Ge, Changwei
    Song, Xiuqing
    Yan, Hong
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 70
  • [46] Novel curcumin-based analogues as potential VEGFR2 inhibitors with promising metallic loading nanoparticles: synthesis, biological evaluation, and molecular modelling investigation
    Yassen, Asmaa S. A.
    Abdel-Wahab, Sherief M.
    Darwish, Khaled M.
    Nafie, Mohamed S.
    Abdelhameed, Reda F. A.
    El-Sayyad, Gharieb S.
    El-Batal, Ahmed I.
    Attia, Khadiga M.
    Elshihawy, Hosam A.
    Elrayess, Ranza
    RSC MEDICINAL CHEMISTRY, 2024, 15 (12): : 4039 - 4067
  • [47] Design, synthesis, in vitro and in silico evaluation of novel substituted 1,2,4-triazole analogues as dual human VEGFR-2 and TB-InhA inhibitors
    Zawal, Amira G.
    Abdel-Aziz, Marwa M.
    Elbatreek, Mahmoud H.
    El-Shanawani, Abdalla A.
    Abdel-Aziz, Lobna M.
    Elbaramawi, Samar S.
    BIOORGANIC CHEMISTRY, 2023, 141
  • [48] 1,5-disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4:: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin
    Odlo, Kristin
    Hentzen, Jean
    dit Chabert, Jeremie Fournier
    Ducki, Sylvie
    Gani, Osman A. B. S. M.
    Sylte, Ingebrigt
    Skrede, Martina
    Florenes, Vivi Ann
    Hansen, Trond Vidar
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (09) : 4829 - 4838
  • [49] Synthesis and biological activity of conformationally restricted analogues of milnacipran:: (1S,2R)-1-phenyl-2-[(R)-1-amino-2-propynyl]-N,N-diethylcyclopropanecarboxamide is a novel class of NMDA receptor channel blocker
    Shuto, S
    Ono, S
    Imoto, H
    Yoshii, K
    Matsuda, A
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) : 3507 - 3514
  • [50] Synthesis and Activity Evaluation of Novel 3,4-Dihydro-benzo[b]-oxazepin-5(2H)-one Derivatives as Protein Kinases Inhibitors
    Hou, Guige
    Jiang, Chengshi
    Liu, Hongchun
    Tong, Linjiang
    Peng, Xia
    Ji, Yinchun
    Geng, Meiyu
    Xiao, Wei
    Gong, Jingxu
    Guo, Yuewei
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2017, 37 (06) : 1463 - 1472